外周血绝对淋巴细胞计数在急性淋巴细胞白血病
预后中的意义

doi:10.3760/cma.j.issn.1673-422X.2018.01.011

摘要/Abstract

摘要： 急性淋巴细胞白血病（ALL）的预后受多种因素影响，其中外周血绝对淋巴细胞计数（ALC）作为一种简单、低廉的预后指标越来越受到关注，相关研究显示，诱导治疗期间不同时间点ALC及其比值在评估ALL预后中显示出重要价值，有望为后续个体化治疗提供依据。

关键词: 白血病, 淋巴样；淋巴细胞计数；预后

Abstract: The prognosis of acute lymphoblastic leukemia (ALL) is affected by multiple factors. As a simple and inexpensive prognostic indicator, the peripheral blood absolute lymphocyte count (ALC) is more and more concerned. Relevant studies show that ALC values of different time points during induction therapy and its ratio show important value in the assessment of ALL prognosis, which is expected to provide a basis for subsequent individualized treatment.

Key words: Leukemia, lymphoid, Lymphocyte count, Prognosis

李丛池，侯丽虹. 外周血绝对淋巴细胞计数在急性淋巴细胞白血病预后中的意义[J]. 国际肿瘤学杂志, 2018, 45(1): 49-.

Li Congchi*, Hou Lihong. Prognostic significance of peripheral blood absolute lymphocyte count in acute lymphoblastic leukemia[J]. Journal of International Oncology, 2018, 45(1): 49-.

参考文献

［1］ Ram R, Wolach O, Vidal L, et al. Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediaticinspired regimens: systematic review and metaanalysis［J］. Am J Hematol, 2012, 87(5): 472478. DOI: 10.1002/ajh.23149. ［2］ Rabin KR, Gramatges MM, Borowitz MJ, et al. Absolute lymphocyte counts refine minimal residual diseasebased risk stratification in childhood acute lymphoblastic leukemia［J］. Pediatr Blood Cancer, 2012, 59(3): 468474. DOI: 10.1002/pbc.23395. ［3］ LopezLastra S, Di Santo JP. Modeling natural killer cell targeted immunotherapies［J］. Front Immunol, 2017, 8: 370. DOI: 10.3389/fimmu.2017.00370. ［4］ Preethy S, Dedeepiya VD, Senthilkumar R, et al. Natural killer cells as a promising tool to tackle cancera review of sources, methodologies, and potentials［J］. Int Rev Immunol, 2017, 36(4): 220232. DOI: 10.1080/08830185.2017.1284209. ［5］ Aerts JG, Hegmans JP. Tumorspecific cytotoxic T cells are crucial for efficacy of immunomodulatory antibodies in patients with lung cancer［J］. Cancer Res, 2013, 73(8): 23812388. DOI: 10.1158/00085472.CAN123932. ［6］ Shen C, Cheng K, Miao S, et al. Latex beadbased artificial antigenpresenting cells induce tumorspecific CTL responses in the native Tcell repertoires and inhibit tumor growth［J］. Immunol Lett, 2013, 150(12): 111. DOI: 10.1016/j.imlet.2013.01.003. ［7］许秀华, 向晓星. CD4+ T细胞在肝细胞癌中的作用［J］. 国际肿瘤学杂志, 2013, 40(10): 785788. DOI: 10.3760/cma.j.issn.1673422X.2013.10.020. ［8］郑智, 方泽民, 潘友民, 等. B细胞与肿瘤免疫的研究进展［J］. 现代肿瘤医学, 2012, 20(12): 26522654. DOI: 10.3969/j.issn.16724992.2012.12.76. ［9］ Feng J, Wang Z, Guo X, et al. Prognostic significance of absolute lymphocyte count at diagnosis of diffuse large Bcell lymphoma: a metaanalysis［J］. Int J Hematol, 2012, 95(2): 143148. DOI: 10.1007/s1218501109936. ［10］ Kim Y, Kim SJ, Cheong JW, et al. Clinical impact of early recovery of peripheral blood absolute lymphocyte count after frontline autologous stem cell transplantation for diffuse large Bcell lymphoma［J］. Hematol Oncol, 2016, In press. DOI: 10.1002/hon.2332. ［11］ Suriu C, Akria L, Azoulay D, et al. Absolute lymphocyte count as a prognostic marker in newly diagnosed multiple myeloma patients［J］. Int J Lab Hematol, 2016, 38(3): e56e59. DOI: 10.1111/ijlh.12482. ［12］ Narwani V, Gabriel J, Boyd K, et al. Absolute lymphocyte count at day 29 of treatment is a powerful predictor of outcome in multiple myeloma［J］. Clin Lymphoma Myeloma Leuk, 2015, 15(4): 222226. DOI: 10.1016/j.clml.2014.10.002. ［13］ Bayraktar UD, Milton DR, Guindani M, et al. Optimal threshold and time of absolute lymphocyte count assessment for outcome prediction after bone marrow transplantation［J］. Biol Blood Marrow Transplant, 2016, 22(3): 505513. DOI: 10.1016/j.bbmt.2015.10.020. ［14］ Fungpipat P, Sophonphan J, Sosothikul D, et al. Redefining clinical risk classification in children with precursor B cell acute lymphoblastic leukemia using pretreatment absolute lymphocyte count［J］. Leuk Lymphoma, 2016, 57(4): 953956. DOI: 10.3109/10428194.2015.1081194. ［15］ Gupta A, Kapoor G, Jain S, et al. Absolute lymphocyte count recovery independently predicts outcome in childhood acute lymphoblastic leukemia: experience from a tertiary care cancer center of a developing country［J］. J Pediatr Hematol Oncol, 2015, 37(3): e143e149. DOI: 10.1097/MPH.0000000000000249. ［16］ Hirase S, Hasegawa D, Takahashi H, et al. Absolute lymphocyte count at the end of induction therapy is a prognostic factor in childhood acute lymphoblastic leukemia［J］. Int J Hematol, 2015, 102(5): 594601. DOI: 10.1007/s1218501518750. ［17］ Farkas T, Müller J, Erdelyi DJ, et al. Absolute lymphocyte count (ALC) after induction treatment predicts survival of pediatric patients with acute lymphoblastic leukemia［J］. Pathol Oncol Res, 2017, 23(4): 889897. DOI: 10.1007/s1225301701928. ［18］黎巧茹, 柯志勇, 谭惠珍, 等. 儿童急性淋巴细胞白血病诱导治疗结束时外周血淋巴细胞数与预后的关系［J］. 热带医学杂志, 2016, 10(16): 12671271. DOI: 16723619(2016)10126705. ［19］ Cheng Y, Luo Z, Yang S, et al. The ratio of absolute lymphocyte count at interim of therapy to absolute lymphocyte count at diagnosis predicts survival in childhood Blineage acute lymphoblastic leukemia［J］. Leuk Res, 2015, 39(2): 144150. DOI: 10.1016/j.leukres.2014.11.013. ［20］ Shen HQ, Feng JH, Tang YM, et al. Absolute lymphocyte count is associated with minimal residual disease level in childhood Bcell precursor acute lymphoblastic leukemia［J］. Leuk Res, 2013, 37(6): 671674. DOI: 10.1016/j.leukres.2013.02.002. ［21］ Rubnitz JE, Campbell P, Zhou Y, et al. Prognostic impact of absolute lymphocyte counts at the end of remission induction in childhood acute lymphoblastic leukemia［J］. Cancer, 2013, 119(11): 20612066. DOI: 10.1002/cncr.28026. ［22］ Alkayed K. RE: "Lack of prognostic significance of absolute lymphocyte count after intensive induction therapy in childhood acute lymphoblastic leukemia" (PBC120049.R2)［J］. Pediatr Blood Cancer, 2014, 61(1): 184. DOI: 10.1002/pbc.24749. ［23］ Sun D, Elson P, Liedtke M, et al. Absolute lymphocyte count at day 28 independently predicts eventfree and overall survival in adults with newly diagnosed acute lymphoblastic leukemia［J］. Am J Hematol, 2012, 87(10): 957960. DOI: 10.1002/ajh.23279.

[1]	滕远, 李莉娟, 张连生. MCL-1及其抑制剂在血液恶性肿瘤中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(2): 119-122.
[2]	王军, 贾秀红. TGF-β/Smad信号通路与急性白血病[J]. 国际肿瘤学杂志, 2023, 50(8): 498-502.
[3]	王婷, 李文倩, 解友邦. 低氧与急性髓系白血病细胞氧感受通路的相关性[J]. 国际肿瘤学杂志, 2023, 50(8): 503-507.
[4]	邢明泉, 葛洪峰, 张丽侠, 韩浩, 吴维霞. 疑似免疫性血小板减少症的侵袭性自然杀伤细胞白血病1例[J]. 国际肿瘤学杂志, 2023, 50(5): 318-320.
[5]	张婷, 贾秀红. 细胞焦亡在白血病中的研究进展[J]. 国际肿瘤学杂志, 2023, 50(11): 696-700.
[6]	陆佳玲, 黄慧娟, 刘丹, 陈妍心, 马骁, 吴德沛. 博纳吐单抗治疗急性B淋巴细胞白血病的疗效和安全性[J]. 国际肿瘤学杂志, 2022, 49(8): 494-498.
[7]	周欣宇, 贾秀红. 铁死亡在白血病治疗中的研究进展[J]. 国际肿瘤学杂志, 2022, 49(12): 759-762.
[8]	陈曦, 母丹, 严钦, 刘文君. 骨髓微环境与白血病细胞分化[J]. 国际肿瘤学杂志, 2021, 48(3): 189-192.
[9]	李伟强, 吴洋, 万崇华, 谭健烽, 何争春, 孟琼. 基于分布法的癌症患者生命质量测定量表体系之白血病量表的最小临床重要性差值制定[J]. 国际肿瘤学杂志, 2021, 48(10): 577-582.
[10]	李转丽, 张君玲, 石亚军, 白海. 伴DDX41体细胞突变及TP53双突变急性髓系白血病一例[J]. 国际肿瘤学杂志, 2021, 48(10): 638-640.
[11]	许蕾, 戴婧, 张倩, 张文丽, 李晋萌, 张红宇. 93例成人急性淋巴细胞白血病的临床分析[J]. 国际肿瘤学杂志, 2020, 47(9): 535-541.
[12]	孙王男, 都鹏超, 齐福, 王文凤, 姜国胜. miR-5581-5p/TRIM22在急性早幼粒细胞白血病细胞分化中的作用[J]. 国际肿瘤学杂志, 2020, 47(3): 129-134.
[13]	洪梨, 王玉, 张琦, 吕成芳. 尼洛替尼一线治疗慢性髓系白血病的进展[J]. 国际肿瘤学杂志, 2020, 47(1): 56-59.
[14]	雷林，吉勇，尚庆刚，彭绩，任骅. 深圳市2001—2015年白血病流行特征和时间趋势[J]. 国际肿瘤学杂志, 2019, 46(7): 415-419.
[15]	斯赛女, 王华英, 俞万钧, 李纪鹏. 白血病抑制因子在肿瘤发生发展中的作用 [J]. 国际肿瘤学杂志, 2019, 46(10): 605-608.